Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Assets: 2014-2020

Historic Return on Assets for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to -0.91%.

  • Larimar Therapeutics' Return on Assets fell 41.00% to -0.91% in Q1 2020 from the same period last year, while for Mar 2020 it was -0.91%, marking a year-over-year decrease of 41.00%. This contributed to the annual value of -0.72% for FY2019, which is 18.00% down from last year.
  • Larimar Therapeutics' Return on Assets amounted to -0.91% in Q1 2020, which was up 1.76% from -0.93% recorded in Q4 2019.
  • Over the past 5 years, Larimar Therapeutics' Return on Assets peaked at -0.42% during Q4 2016, and registered a low of -0.93% during Q4 2019.
  • Moreover, its 3-year median value for Return on Assets was -0.55% (2018), whereas its average is -0.63%.
  • Examining YoY changes over the last 5 years, Larimar Therapeutics' Return on Assets showed a top increase of 15bps in 2019 and a maximum decrease of 44bps in 2019.
  • Over the past 5 years, Larimar Therapeutics' Return on Assets (Quarterly) stood at -0.42% in 2016, then declined by 10bps to -0.52% in 2017, then rose by 4bps to -0.48% in 2018, then slumped by 44bps to -0.93% in 2019, then tumbled by 41bps to -0.91% in 2020.
  • Its Return on Assets was -0.91% in Q1 2020, compared to -0.93% in Q4 2019 and -0.54% in Q3 2019.